Molecular Mechanisms Underlying the Anticancer Properties of Pitavastatin against Cervical Cancer Cells
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25147915 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Ya-Hui Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Women's Health Research Laboratory, Changhua Christian Hospital, Changhua 50006, Taiwan. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Quinolines, Apoptosis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Changhua Christian Hospital.
Abstract (Originalsprache)
Cervical cancer ranks as the fourth most prevalent form of cancer and is a significant contributor to female mortality on a global scale. Pitavastatin is an anti-hyperlipidemic medication and has been demonstrated to exert anticancer and anti-inflammatory effects. Thus, the purpose of this study was to evaluate the anticancer effect of pitavastatin on cervical cancer and the underlying molecular mechanisms involved. The results showed that pitavastatin significantly inhibited cell viability by targeting cell-cycle arrest and apoptosis in Ca Ski, HeLa and C-33 A cells. Pitavastatin caused sub-G1- and G0/G1-phase arrest in Ca Ski and HeLa cells and sub-G1- and G2/M-phase arrest in C-33 A cells. Moreover, pitavastatin induced apoptosis via the activation of poly-ADP-ribose polymerase (PARP), Bax and cleaved caspase 3; inactivated the expression of Bcl-2; and increased mitochondrial membrane depolarization. Furthermore, pitavastatin induced apoptosis and slowed the migration of all three cervical cell lines, mediated by the PI3K/AKT and MAPK (JNK, p38 and ERK1/2) pathways. Pitavastatin markedly inhibited tumor growth in vivo in a cancer cell-originated xenograft mouse model. Overall, our results identified pitavastatin as an anticancer agent for cervical cancer, which might be expanded to clinical use in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Women's Health Research Laboratory, Changhua Christian Hospital, Changhua 50006, Taiwan.
- Institute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan.
- Department of Medical Research, Chung Shan Medical University Hospital, Taichung 40201, Taiwan.
- Department of Obstetrics and Gynecology, Changhua Christian Hospital, Changhua 50006, Taiwan.
- School of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan.
- College of Medicine, Kaohsiung Medical University, Kaohsiung 807378, Taiwan.
ORCID-Profile: Shun-Fa Yang
Förderung
- Changhua Christian Hospital
Zitieren
APA
Chen, Y. H., Wu, J. X., Yang, S. F., Wu, Y. C., & Hsiao, Y. H. (2024). Molecular Mechanisms Underlying the Anticancer Properties of Pitavastatin against Cervical Cancer Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25147915
Vancouver
Chen YH, Wu JX, Yang SF, Wu YC, Hsiao YH. Molecular Mechanisms Underlying the Anticancer Properties of Pitavastatin against Cervical Cancer Cells. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25147915
BibTeX
@article{Chen2024,
author = {Chen, Ya-Hui and Wu, Jyun-Xue and Yang, Shun-Fa and Wu, Yun-Chia and Hsiao, Yi-Hsuan},
title = {Molecular Mechanisms Underlying the Anticancer Properties of Pitavastatin against Cervical Cancer Cells},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25147915}
}
EUVIMED